Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease: Review and hypothesis

Neurobiology of Aging

Volumn 27, Issue 2, 2006, Pages 190-198

  Qiu, Wei Qiao ^a,b   Folstein, Marshal F ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Amyloid peptide; Insulin; Insulin degrading enzyme; Type 2 diabetes and Alzheimer's disease

Indexed keywords

AMYLIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; INSULIN; INSULINASE;

ALLELE; ALZHEIMER DISEASE; DISEASE ASSOCIATION; ENZYME DEFICIENCY; GENETIC VARIABILITY; HUMAN; HYPERINSULINEMIA; INSULIN METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; REVIEW; RISK ASSESSMENT; SYMPTOM;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERINSULINISM; INSULIN; INSULYSIN; MODELS, BIOLOGICAL; RISK;

EID: 29844432266     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2005.01.004     Document Type: Review

References (97)

1. R. Abraham, A. Myers, F. Wavrant-DeVrieze, M.L. Hamshere, H.V. Thomas, H. Marshall, D. Compton, G. Spurlock, D. Turic, B. Hoogendoorn, J.M. Kwon, R.C. Petersen, E. Tangalos, J. Norton, J.C. Morris, R. Bullock, D. Liolitsa, S. Lovestone, J. Hardy, A. Goate, M. O'Donovan, J. Williams, M.J. Owen, and L. Jones Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease Hum Genet 109 2001 646 652
2. J.A. Affholter, V.A. Fried, and R.A. Roth Human insulin-degrading enzyme shares structural and functional homologies with E. coli protease III Science 242 1988 1415 1418
3. G. Ait-Ghezala, L. Abdullah, R. Crescentini, F. Crawford, T. Town, S. Singh, D. Richards, R. Duara, and M. Mullan Confirmation of association between D10S583 and Alzheimer's disease in a case-control sample Neurosci Lett 325 2002 87 90
4. Z. Arvanitakis, R.S. Wilson, J.L. Bienias, D.A. Evans, and D.A. Bennett Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function Archiv Neurol 61 2004 661 666
5. F. Authier, B.I. Posner, and J.J. Bergeron Insulin-degrading enzyme Clin Invest Med 19 1996 149 160
6. H. Baumeister, D. Muller, M. Rehbein, and D. Richter The rat insulin-degrading enzyme. Molecular cloning and characterization of tissue-specific transcripts FEBS Lett 317 1993 250 254
7. A.B. Becker, and R.A. Roth Insulysin and pitrilysin: insulin-degrading enzymes of mammals and bacteria Meth Enzymol 248 1995 693 703
8. R.G. Bennett, W.C. Duckworth, and F.G. Hamel Degradation of amylin by insulin-degrading enzyme J Biol Chem 275 2000 36621 36625
9. R.G. Bennett, W.C. Duckworth, and F.G. Hamel Degradation of amylin by insulin-degrading enzyme Identification and isolation of a cytosolic proteolytic complex containing insulin degrading enzyme and the multicatalytic proteinase J Biol Chem 275 2000 36621 36625
10. R.G. Bennett, F.G. Hamel, and W.C. Duckworth Identification and isolation of a cytosolic proteolytic complex containing insulin degrading enzyme and the multicatalytic proteinase Biochem Biophys Res Commun 202 1994 1047 1053
11. L. Bertram, D. Blacker, K. Mullin, D. Keeney, J. Jones, S. Basu, S. Yhu, M.G. McInnis, R.C. Go, K. Vekrellis, D.J. Selkoe, A.J. Saunders, and R.E. Tanzi Evidence for genetic linkage of Alzheimer's disease to chromosome 10q Science 290 2000 2302 2303
12. M. Boussaha, D. Hannequin, P. Verpillat, A. Brice, T. Frebourg, and D. Campion Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease Neurosci Lett 329 2002 121 123
13. A.A. Boyt, T.K. Taddei, J. Hallmayer, E. Helmerhorst, S.E. Gandy, S. Craft, and R.N. Martins The effect of insulin and glucose on the plasma concentration of Alzheimer's amyloid precursor protein Neuroscience 95 2000 727 734
14. M. Carantoni, G. Zuliani, M.R. Munari, K. D'Elia, E. Palmieri, and R. Fellin Alzheimer disease and vascular dementia: relationships with fasting glucose and insulin levels Dement Geriatr Cogn Disord 11 2000 176 180
15. D.G. Cook, J.B. Leverenz, P.J. McMillan, J.J. Kulstad, S. Ericksen, R.A. Roth, G.D. Schellenberg, L.W. Jin, K.S. Kovacina, and S. Craft Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele Am J Pathol 162 2003 313 319
16. S. Craft, S. Asthana, G. Schellenberg, L. Baker, M. Cherrier, A.A. Boyt, R.N. Martins, M. Raskind, E. Peskind, S. Plymate, L.D. Baker, J. Newcomer, S. Latendresse, A. Petrova, C. Lofgreen, and K. Grimwood Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender Ann NY Acad Sci 903 2000 222 228
17. S. Craft, S. Asthana, G. Schellenberg, M. Cherrier, L.D. Baker, J. Newcomer, S. Plymate, S. Latendresse, A. Petrova, M. Raskind, E. Peskind, C. Lofgreen, and K. Grimwood Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender Neuroendocrinology 70 1999 146 152
18. S. Craft, E. Peskind, M.W. Schwartz, G.D. Schellenberg, M. Raskind, and D. Porte Jr. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype Neurology 50 1998 164 168
19. K.N. Dahlgren, A.M. Manelli, W.B. Stine Jr., L.K. Baker, G.A. Krafft, and M.J. LaDu Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability J Biol Chem 277 2002 32046 32053
20. J.C. de la Torre Alzheimer disease as a vascular disorder: nosological evidence Stroke 33 2002 1152 1162
21. R. Duggirala, J. Blangero, L. Almasy, R. Arya, T.D. Dyer, K.L. Williams, R.J. Leach, P. O'Connell, and M.P. Stern A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans Am J Hum Genet 68 2001 1149 1164
22. R. Duggirala, J. Blangero, L. Almasy, T.D. Dyer, K.L. Williams, R.J. Leach, P. O'Connell, and M.P. Stern Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans Am J Hum Genet 64 1999 1127 1140
23. S.D. Edland, S. Slager, M. Farrer, F. Wavrant-De Vriese, D. Compton, G.E. Smith, R. Ivnik, B.F. Boeve, E.G. Tangalos, and R.C. Petersen Insulin-degrading enzyme, apolipoprotein E, and Alzheimer's disease. Genetic association studies in Alzheimer's disease research: challenges and opportunities insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE) J Mol Neurosci 23 2004 213 217
24. S.D. Edland, F. Wavrant-De Vriese, D. Compton, G.E. Smith, R. Ivnik, B.F. Boeve, E.G. Tangalos, and R.C. Petersen Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE) Neurosci Lett 345 2003 21 24
25. N. Ertekin-Taner, M. Allen, D. Fadale, L. Scanlin, L. Younkin, R.C. Petersen, N. Graff-Radford, and S.G. Younkin Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease Hum Mutat 23 2004 334 342
26. H. Fakhrai-Rad, A. Nikoshkov, A. Kamel, M. Fernstrom, J.R. Zierath, S. Norgren, H. Luthman, and J. Galli Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats Hum Mol Genet 9 2000 2149 2158
27. W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E.A. Eckman, M.P. Frosch, C.B. Eckman, R.E. Tanzi, D.J. Selkoe, and S. Guenette Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo Proc Natl Acad Sci USA 100 2003 4162 4167
28. W. Farris, S. Mansourian, M.A. Leissring, E.A. Eckman, L. Bertram, C.B. Eckman, R.E. Tanzi, and D.J. Selkoe Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein Am J Pathol 164 2004 1425 1434
29. L. Frolich, D. Blum-Degen, H.G. Bernstein, S. Engelsberger, J. Humrich, S. Laufer, D. Muschner, A. Thalheimer, A. Turk, S. Hoyer, R. Zochling, K.W. Boissl, K. Jellinger, and P. Riederer Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease J Neural Transm 105 1998 423 438
30. Y. Fujisawa, K. Sasaki, and K. Akiyama Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type Biol Psychiatr 30 1991 1219 1228
31. L. Gasparini, G.K. Gouras, R. Wang, R.S. Gross, M.F. Beal, P. Greengard, and H. Xu Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling J Neurosci 21 2001 2561 2570
32. L. Gasparini, W.J. Netzer, P. Greengard, and H. Xu Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol Sci 23 2002 288 293
33. G.G. Glenner, and C.W. Wong Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein Biochem Biophys Res Commun 120 1984 885 890
34. F. Grodstein, J. Chen, R.S. Wilson, and J.E. Manson Type 2 diabetes and cognitive function in community-dwelling elderly women Diabetes Care 24 2001 1060 1065
35. C.J. Groves, S. Wiltshire, D. Smedley, K.R. Owen, T.M. Frayling, M. Walker, G.A. Hitman, J.C. Levy, S. O'Rahilly, S. Menzel, A.T. Hattersley, and M.I. McCarthy Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility Diabetes 52 2003 1300 1305
36. H.F. Gu, S. Efendic, S. Nordman, C.G. Ostenson, K. Brismar, A.J. Brookes, and J.A. Prince Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels Diabetes 53 2004 2137 2142
37. J. Hari, K. Shii, and R.A. Roth In vivo association of [125I]-insulin with a cytosolic insulin-degrading enzyme: detection by covalent cross-linking and immunoprecipitation with a monoclonal antibody Endocrinology 120 1987 829 831
38. H. Hattori, M. Matsumoto, H. Tsuchiya, K. Iwai, E. Miyauchi, M. Takasaki, J. Munehira, and K. Kawanishi An elderly patient with an insulinoma who had prolonged dementia-like symptoms Nippon Ronen Igakkai Zasshi 35 1998 566 570
39. J. Havrankova, D. Schmechel, J. Roth, and M. Brownstein Identification of insulin in rat brain Proc Natl Acad Sci USA 75 1978 5737 5741
40. S. Hoyer The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update J Neural Transm 109 2002 341 360
41. J. Janson, T. Laedtke, J.E. Parisi, P. O'Brien, R.C. Petersen, and P.C. Butler Increased risk of type 2 diabetes in Alzheimer disease Diabetes 53 2004 474 481
42. S.E. Kahn, S. Andrikopoulos, and C.B. Verchere Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes Diabetes 48 1999 241 253
43. S. Karamohamed, S. Demissie, J. Volcjak, C. Liu, N. Heard-Costa, J. Liu, C.M. Shoemaker, C.I. Panhuysen, J.B. Meigs, P. Wilson, L.D. Atwood, L.A. Cupples, and A. Herbert Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study Diabetes 52 2003 1562 1567
44. R.J. Kirschner, and A.L. Goldberg A high molecular weight metalloendoprotease from the cytosol of mammalian cells J Biol Chem 258 1983 967 976
45. W.L. Kuo, B.D. Gehm, M.R. Rosner, W. Li, and G. Keller Inducible expression and cellular localization of insulin-degrading enzyme in a stably transfected cell line J Biol Chem 269 1994 22599 22606
46. W.L. Kuo, A.G. Montag, and M.R. Rosner Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues Endocrinology 132 1993 604 611
47. I.V. Kurochkin Insulin-degrading enzyme: embarking on amyloid destruction Trends Biochem Sci 26 2001 421 425
48. I.V. Kurochkin, and S. Goto Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme FEBS Lett 345 1994 33 37
49. J. Kuusisto, K. Koivisto, L. Mykkanen, E.L. Helkala, M. Vanhanen, T. Hanninen, K. Kervinen, Y.A. Kesaniemi, P.J. Riekkinen, and M. Laakso Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study BMJ 315 1997 1045 1049
50. M. Laakso How good a marker is insulin level for insulin resistance? Am J Epidemiol 137 1993 959 965
51. C.L. Leibson, W.A. Rocca, V.A. Hanson, R. Cha, E. Kokmen, P.C. O'Brien, and P.J. Palumbo The risk of dementia among persons with diabetes mellitus: a population-based cohort study Ann NY Acad Sci 826 1997 422 427
52. M.A. Leissring, W. Farris, A.Y. Chang, D.M. Walsh, X. Wu, X. Sun, M.P. Frosch, and D.J. Selkoe Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death Neuron 40 2003 1087 1093
53. Y.J. Li, W.K. Scott, D.J. Hedges, F. Zhang, P.C. Gaskell, M.A. Nance, R.L. Watts, J.P. Hubble, W.C. Koller, R. Pahwa, M.B. Stern, B.C. Hiner, J. Jankovic, F.A. Allen Jr., C.G. Goetz, F. Mastaglia, J.M. Stajich, R.A. Gibson, L.T. Middleton, A.M. Saunders, B.L. Scott, G.W. Small, K.K. Nicodemus, A.D. Reed, D.E. Schmechel, K.A. Welsh-Bohmer, P.M. Conneally, A.D. Roses, J.R. Gilbert, J.M. Vance, J.L. Haines, and M.A. Pericak-Vance Age at onset in two common neurodegenerative diseases is genetically controlled Am J Hum Genet 70 2002 985 993
54. Y. Ling, K. Morgan, and N. Kalsheker Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease Int J Biochem Cell Biol 35 2003 1505 1535
55. J.A. Luchsinger, M.X. Tang, S. Shea, and R. Mayeux Hyperinsulinemia and risk of Alzheimer disease Neurology 63 2004 1187 1192
56. J.A. Luchsinger, M.X. Tang, Y. Stern, S. Shea, and R. Mayeux Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort Am J Epidemiol 154 2001 635 641
57. J.R. McDermott, and A.M. Gibson Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme Neurochem Res 22 1997 49 56
58. B.C. Miller, E.A. Eckman, K. Sambamurti, N. Dobbs, K.M. Chow, C.B. Eckman, L.B. Hersh, and D.L. Thiele Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo Proc Natl Acad Sci USA 100 2003 6221 6226
59. R.I. Misbin, and E.C. Almira Degradation of insulin and insulin-like growth factors by enzyme purified from human erythrocytes. Comparison of degradation products observed with A14- and B26-[125I]monoiodoinsulin Diabetes 38 1989 152 158
60. J.A. Molina, F.J. Jimenez-Jimenez, C. Vargas, P. Gomez, F. de Bustos, C. Gomez-Escalonilla, M. Zurdo, A. Tallon, A. Martinez-Salio, J. Porta-Etessam, C. Villanueva, and J. Arenas Cerebrospinal fluid levels of insulin in patients with Alzheimer's disease Acta Neurol Scand 106 2002 347 350
61. L. Morelli, R. Llovera, S.A. Gonzalez, J.L. Affranchino, F. Prelli, B. Frangione, J. Ghiso, and E.M. Castano Differential degradation of amyloid beta genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme J Biol Chem 278 2003 23221 23226
62. A. Mukherjee, E. Song, M. Kihiko-Ehmann, J.P. Goodman Jr., J.S. Pyrek, S. Estus, and L.B. Hersh Insulysin hydrolyzes amyloid beta peptides to products that are neither neurotoxic nor deposit on amyloid plaques J Neurosci 20 2000 8745 8749
63. A. Myers, P. Holmans, H. Marshall, J. Kwon, D. Meyer, D. Ramic, S. Shears, J. Booth, F.W. DeVrieze, R. Crook, M. Hamshere, R. Abraham, N. Tunstall, F. Rice, S. Carty, S. Lillystone, P. Kehoe, V. Rudrasingham, L. Jones, S. Lovestone, J. Perez-Tur, J. Williams, M.J. Owen, J. Hardy, and A.M. Goate Susceptibility locus for Alzheimer's disease on chromosome 10 Science 290 2000 2304 2305
64. A.J. Myers, and A.M. Goate The genetics of late-onset Alzheimer's disease Curr Opin Neurol 14 2001 433 440
65. K.A. Nielson, J.H. Nolan, N.C. Berchtold, C.A. Sandman, R.A. Mulnard, and C.W. Cotman Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease? J Am Geriatr Soc 44 1996 897 904
66. W. Ogawa, K. Shii, K. Yonezawa, S. Baba, and K. Yokono Affinity purification of insulin-degrading enzyme and its endogenous inhibitor from rat liver J Biol Chem 267 1992 1310 1316
67. A. Ott, R.P. Stolk, A. Hofman, F. van Harskamp, D.E. Grobbee, and M.M. Breteler Association of diabetes mellitus and dementia: the Rotterdam study Diabetologia 39 1996 1392 1397
68. A. Ott, R.P. Stolk, F. van Harskamp, H.A. Pols, A. Hofman, and M.M. Breteler Diabetes mellitus and the risk of dementia: the Rotterdam study Neurology 53 1999 1937 1942
69. G.N. Patrick, L. Zukerberg, M. Nikolic, S. de La Monte, P. Dikkes, and L.H. Tsai Reply: neurobiologyp25 protein in neurodegeneration Nature 411 2001 764 765
70. R. Peila, B.L. Rodriguez, and L.J. Launer Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study Diabetes 51 2002 1256 1262
71. A. Perez, L. Morelli, J.C. Cresto, and E.M. Castano Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains Neurochem Res 25 2000 247 255
72. J.A. Prince, L. Feuk, H.F. Gu, B. Johansson, M. Gatz, K. Blennow, and A.J. Brookes Genetic variation in a haplotype block spanning IDE influences Alzheimer disease Hum Mutat 22 2003 363 371
73. W.Q. Qiu, D.M. Walsh, Z. Ye, K. Vekrellis, J. Zhang, M.B. Podlisny, M.R. Rosner, A. Safavi, L.B. Hersh, and D.J. Selkoe Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation J Biol Chem 273 1998 32730 32738
74. W.Q. Qiu, Z. Ye, D. Kholodenko, P. Seubert, and D.J. Selkoe Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other neural and non-neural cells J Biol Chem 272 1997 6641 6646
75. G. Razay, and G.K. Wilcock Hyperinsulinaemia and Alzheimer's disease Age Ageing 23 1994 396 399
76. K. Runyan, W.C. Duckworth, A.E. Kitabchi, and G. Huff The effect of age on insulin-degrading activity in rat tissue Diabetes 28 1979 324 325
77. T. Saric, D. Muller, H.J. Seitz, and K. Pavelic Non-covalent interaction of ubiquitin with insulin-degrading enzyme Mol Cell Endocrinol 204 2003 11 20
78. D.J. Selkoe Aging, amyloid, and Alzheimer's disease: a perspective in honor of Carl Cotman Neurochem Res 28 2003 1705 1713
79. K. Shii, and R.A. Roth Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease Proc Natl Acad Sci USA 83 1986 4147 4151
80. A.J. Sinclair, A.J. Girling, and A.J. Bayer Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales research into elderly (AWARE) study Diabetes Res Clin Pract 50 2000 203 212
81. D.C. Solano, M. Sironi, C. Bonfini, S.B. Solerte, S. Govoni, and M. Racchi Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway FASEB J 14 2000 1015 1022
82. E.S. Song, M.A. Juliano, L. Juliano, and L.B. Hersh Substrate activation of insulin-degrading enzyme (insulysin). A potential target for drug development J Biol Chem 278 2003 49789 49794
83. R. Stewart, and D. Liolitsa Type 2 diabetes mellitus, cognitive impairment and dementia Diabet Med 16 1999 93 112
84. R.P. Stolk, M.M. Breteler, A. Ott, H.A. Pols, S.W. Lamberts, D.E. Grobbee, and A. Hofman Insulin and cognitive function in an elderly population. The Rotterdam study Diabetes Care 20 1997 792 795
85. W.J. Strittmatter, A.M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G.S. Salvesen, and A.D. Roses Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease Proc Natl Acad Sci USA 90 1993 1977 1981
86. R.E. Tanzi, and L. Bertram New frontiers in Alzheimer's disease genetics Neuron 32 2001 181 184
87. P.N. Tariot, M.A. Ogden, C. Cox, and T.F. Williams Diabetes and dementia in long-term care J Am Geriatr Soc 47 1999 423 429
88. J.T. Tschanz, C. Corcoran, I. Skoog, A.S. Khachaturian, J. Herrick, K.M. Hayden, K.A. Welsh-Bohmer, T. Calvert, M.C. Norton, P. Zandi, and J.C. Breitner Dementia: the leading predictor of death in a defined elderly population: the Cache County study Neurology 62 2004 1156 1162
89. M. Vanhanen, K. Koivisto, J. Kuusisto, L. Mykkanen, E.L. Helkala, T. Hanninen, P. Riekkinen Sr., H. Soininen, and M. Laakso Cognitive function in an elderly population with persistent impaired glucose tolerance Diabetes Care 21 1998 398 402
90. K. Vekrellis, Z. Ye, W.Q. Qiu, D. Walsh, D. Hartley, V. Chesneau, M.R. Rosner, and D.J. Selkoe Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme J Neurosci 20 2000 1657 1665
91. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, M.S. Wolfe, M.J. Rowan, and D.J. Selkoe Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539
92. G.S. Watson, E.R. Peskind, S. Asthana, K. Purganan, C. Wait, D. Chapman, M.W. Schwartz, S. Plymate, S. Craft, G. Schellenberg, L. Baker, M. Cherrier, A.A. Boyt, R.N. Martins, M. Raskind, E. Peskind, L.D. Baker, J. Newcomer, S. Latendresse, A. Petrova, C. Lofgreen, and K. Grimwood Insulin increases CSF Abeta42 levels in normal older adults. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype. Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender Neurology 60 2003 1899 1903
93. C. Weyer, R.L. Hanson, P.A. Tataranni, C. Bogardus, and R.E. Pratley A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia Diabetes 49 2000 2094 2101
94. I. Wickelgren Tracking insulin to the mind Science 280 1998 517 519
95. L. Xie, E. Helmerhorst, K. Taddei, B. Plewright, W. Van Bronswijk, and R. Martins Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor J Neurosci 22 2002 RC221
96. W.L. Xu, C.X. Qiu, A. Wahlin, B. Winblad, and L. Fratiglioni Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study Neurology 63 2004 1181 1186
97. W. Zhao, H. Chen, H. Xu, E. Moore, N. Meiri, M.J. Quon, and D.L. Alkon Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats J Biol Chem 274 1999 34893 34902